Related Experiment Videos
Anti-inflammatory drugs and experimental bronchitis.
European Journal of Respiratory Diseases. Supplement
|January 1, 1986
Summary
Cigarette smoke causes airway changes like mucous cell hyperplasia in rats. Drugs such as indomethacin, flurbiprofen, and N-acetylcysteine (Nac) can inhibit these changes and aid recovery.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Respiratory Pathology
Background:
- Chronic bronchitis and bronchiolitis, linked to smoking, cause airflow obstruction and lung function decline.
- Histologically, these conditions feature mucous metaplasia and hyperplasia in the airways.
Purpose of the Study:
- To establish a rat model for studying cigarette smoke-induced airway changes.
- To investigate the inhibitory effects of specific drugs on these experimentally induced changes.
Main Methods:
- Specific pathogen-free rats were exposed to cigarette smoke daily for two weeks.
- The prophylactic administration of indomethacin, flurbiprofen, dexamethasone, prednisolone, hydrocortisone, or N-acetylcysteine (Nac) was evaluated.
- Histological changes and recovery times of secretory cell hyperplasia were assessed.
Main Results:
- Cigarette smoke exposure induced basal cell proliferation, mucous metaplasia, and mucous cell hyperplasia in rat airways.
- Secretory cell hyperplasia was inhibited by indomethacin, flurbiprofen, dexamethasone, prednisolone, hydrocortisone, and Nac.
- Nac also inhibited mucus hypersecretion, and indomethacin/flurbiprofen shortened recovery time in intrapulmonary airways.
Conclusions:
- The rat model successfully replicates cigarette smoke-induced airway mucous cell metaplasia and proliferation.
- Concurrent administration of indomethacin, flurbiprofen, and Nac inhibits cigarette smoke-induced mucous cell hyperplasia.
- These drugs demonstrate therapeutic potential for managing smoking-related airway diseases.